BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice.

Hamouda MA, Jacquel A, Robert G, Puissant A, Richez V, Cassel R, Fenouille N, Roulland S, Gilleron J, Griessinger E, Dubois A, Bailly-Maitre B, Goncalves D, Mallavialle A, Colosetti P, Marchetti S, Amiot M, Gomez-Bougie P, Rochet N, Deckert M, Avet-Loiseau H, Hofman P, Karsenti JM, Jeandel PY, Blin-Wakkach C, Nadel B, Cluzeau T, Anderson KC, Fuzibet JG, Auberger P, Luciano F

Open source

DOI
10.1084/jem.20150983
Published
2016 Aug 22
Container
The Journal of experimental medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1084/jem.20150983,
  title = {BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice.},
  author = {Hamouda MA and Jacquel A and Robert G and Puissant A and Richez V and Cassel R and Fenouille N and Roulland S and Gilleron J and Griessinger E and Dubois A and Bailly-Maitre B and Goncalves D and Mallavialle A and Colosetti P and Marchetti S and Amiot M and Gomez-Bougie P and Rochet N and Deckert M and Avet-Loiseau H and Hofman P and Karsenti JM and Jeandel PY and Blin-Wakkach C and Nadel B and Cluzeau T and Anderson KC and Fuzibet JG and Auberger P and Luciano F},
  year = {2016},
  journal = {The Journal of experimental medicine},
  doi = {10.1084/jem.20150983},
  url = {https://doi.org/10.1084/jem.20150983}
}

RIS

TY  - JOUR
TI  - BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice.
AU  - Hamouda MA
AU  - Jacquel A
AU  - Robert G
AU  - Puissant A
AU  - Richez V
AU  - Cassel R
AU  - Fenouille N
AU  - Roulland S
AU  - Gilleron J
AU  - Griessinger E
AU  - Dubois A
AU  - Bailly-Maitre B
AU  - Goncalves D
AU  - Mallavialle A
AU  - Colosetti P
AU  - Marchetti S
AU  - Amiot M
AU  - Gomez-Bougie P
AU  - Rochet N
AU  - Deckert M
AU  - Avet-Loiseau H
AU  - Hofman P
AU  - Karsenti JM
AU  - Jeandel PY
AU  - Blin-Wakkach C
AU  - Nadel B
AU  - Cluzeau T
AU  - Anderson KC
AU  - Fuzibet JG
AU  - Auberger P
AU  - Luciano F
PY  - 2016
JO  - The Journal of experimental medicine
DO  - 10.1084/jem.20150983
UR  - https://doi.org/10.1084/jem.20150983
ER  - 

APA

MA, H., A, J., G, R., A, P., V, R., R, C., N, F., S, R., J, G., E, G., A, D., B, B., D, G., A, M., P, C., S, M., M, A., P, G., N, R., M, D., H, A., P, H., JM, K., PY, J., C, B., B, N., T, C., KC, A., JG, F., P, A., & F, L. (2016). BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice.. The Journal of experimental medicine. https://doi.org/10.1084/jem.20150983

Source records